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collagen-binding activity, and the loss of the largest multimers, or 
combination of these was present in 67–92% of patients wit
severe AS and correlated signiﬁcantly with the severity of valv
stenosis [5]. Interestingly, these hemostatic abnormalities wer
improved by valve replacement in the absence of mismatc
between patient and prosthesis. Similarly, in obstructive HCM
treatment led to a substantial decrease in peak gradient associate
with an improvement in VWF-related hemostasis as Le Tournea
reported [3].
In our paper, we measured erythrocyte creatine, a sensitive an
quantitative marker for intravascular hemolysis, to examine thn
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2ities with high shear stress
We thank Dr Dimitrow for his interest in our article [1]. In our
paper, we focused on intravascular hemolysis correlated with
severity of left ventricular outﬂow tract (LVOT) obstruction in
hypertrophic cardiomyopathy (HCM) patients [2]. Dr Dimitrow
commented on hematologic characteristics including increased
hypercoagulation, enhanced oxidative stress, and increased
proteolysis of von Willebrand factor (VWF) multimers (acquired
type 2A VW syndrome) in obstructive HCM [1]. Le Tourneau et al.
reported that shear-induced platelet adhesion was impaired in
patients with obstructive HCM, and the ratio of VWF-collagen-
binding activity to antigen and the percentage of high-molecular
weight multimers of VWF were lower in patients with obstructive
HCM than in those with nonobstructive HCM [3]. Furthermore,
platelet adhesion time, VWF-collagen-binding activity-to-antigen
ratio, and the percentage of high-molecular-weight multimers
correlated closely and independently with peak gradient. Acquired
VW syndrome is a recognized risk factor for cutaneous or mucosal
bleeding. From Le Tourneau and colleagues’ observation, obstruc-
tive HCM patients appear to have abnormal spontaneous bleeding
[3].
This phenomenon is also known to be seen in patients with
aortic valve stenosis (AS). The hemorrhagic complication, Heyde’s
syndrome, can occur particularly due to gastrointestinal angio-
dysplasia in AS patients [4], and high shear stress like stenotic
valve is considered to induce structural changes in the shape of the
VWF molecule. According to Vincentelli et al., platelet-function
abnormalities under condition of high shear stress, decreased VWFpresence of subclinical hemolysis and the relation betwee
intravascular hemolysis and intraventricular pressure gradien
in HCM patients, and found that there was biochemical evidence o
subclinical hemolysis, and this hemolysis appeared to b
associated with LVOT obstruction provoked by daily physica
activities [1]. In patients with HCM, estimation of LVOT gradient i
an important issue because it is related to poor outcome. Thes
biochemical assessments may become useful surrogate marker
for the existence of LVOT obstruction.
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